Select Transactions
Filter by
Sector of Focus
August 2021
Investment by NexPhase Capital
Exclusive financial advisor
August 2021
Has been acquired by WellSky
Exclusive financial advisor
July 2021
Series A financing co-led by Providence Ventures and Health Enterprise Partners
Exclusive financial advisor
$15,000,000
May 2021
Series B financing led by TT Capital Partners
Exclusive financial advisor
$25,000,000
January 2021
SwipeSense has been sold to SC Johnson
Exclusive financial advisor
January 2021
First equity investment led by Equality Asset Management
Exclusive financial advisor
January 2021
Has been sold to Cedar Gate Technologies
Exclusive financial advisor
December 2020
Trialscope has been sold to Informa Pharma Intelligence
Exclusive financial advisor
June 2020
Minority equity investment by Perrigo
Exclusive financial advisor
$50,000,000
September 2019
Minority equity investment led by Flexpoint Ford
Exclusive financial advisor
July 2019
Series C financing led by Updata Partners
Exclusive financial advisor
$22,000,000
March 2019
Follow-on
Co-manager
$397,000,000
March 2019
Has been sold to Tabula Rasa Healthcare
Exclusive financial advisor
$150,000,000
March 2019
Follow-on
Co-manager
$275,000,000
January 2019
Follow-on
Co-manager
$105,000,000
January 2019
Has been sold to Cardinal Health
Exclusive financial advisor
August 2018
Minority growth equity investment by Primus
Exclusive financial advisor
$60,000,000
August 2018
Follow-on
Co-manager
$143,692,500
July 2018
Convertible debt
Financial advisor
$200,000,000
June 2018
IPO
Co-manager
$88,200,000
June 2018
Growth equity investment by Mainsail Partners
Exclusive financial advisor
$60,000,000
May 2018
IPO
Co-manager
$310,500,000
January 2018
Has been sold to Daxko
Exclusive financial advisor
January 2018
Convertible senior note
Co-manager
$200,000,000
December 2017
Follow-on
Co-manager
$82,500,000
September 2017
Follow-on
Co-manager
$179,000,000
July 2017
Preferred stock growth investment by Bison Capital
Exclusive placement agent
May 2017
Follow-on
Co-manager
$346,500,000
March 2017
Senior secured notes
Financial advisor
$250,000,000
December 2016
Senior secured notes
Co-manager
$130,000,000
November 2016
Has acquired GPS Heroes
Exclusive financial advisor
October 2016
IPO
Co-manager
$346,500,000
September 2016
Series B convertible preferred stock by Primus
Exclusive placement agent
June 2016
IPO
Co-manager
$91,000,000
May 2016
Series D preferred stock by SSM Partners
Exclusive placement agent
$19,250,000
February 2016
Growth investment by Bison Capital
Exclusive placement agent
December 2015
Has been sold to Daxko
Exclusive financial advisor
September 2015
Follow-on
Co-manager
$105,400,000
September 2015
Follow-on
Co-manager
$119,000,000
June 2015
Convertible senior note
Co-manager
$230,000,000
May 2015
Convertible senior note
Co-manager
$150,000,000
May 2015
Follow-on
Co-manager
$87,000,000
May 2015
Has been sold to ProPharma Group
Exclusive financial advisor
May 2015
Convertible senior note
Financial advisor
$150,000,000
November 2014
Growth investment by Francisco Partners
Exclusive financial advisor
June 2014
Series D preferred stock
Exclusive financial advisor
April 2014
Series C preferred stock growth investment by Bain Capital
Exclusive placement agent
$13,500,000
January 2014
Has been sold to ServiceSource
Exclusive financial advisor
$32,500,000
December 2013
Convertible senior note
Co-manager
$175,000,000
November 2013
Follow-on
Joint book running manager
$22,500,000
November 2013
Registered direct
Co-placement agent
$20,000,000
November 2013
Follow-on
Co-manager
$188,700,000
November 2013
Follow-on
Co-manager
$47,000,000
February 2013
Follow-on
Co-manager
$48,000,000
January 2013
PIPE
Co-lead placement agent
$11,000,000
January 2013
Has been sold to Ascensus
Financial co-advisor
October 2012
Follow-on
Co-manager
$20,000,000
September 2012
IPO
Co-manager
$91,000,000
August 2012
PIPE
Exclusive placement agent
$12,000,000
August 2012
has sold its business and technology assets
Exclusive financial advisor
April 2012
IPO
Co-manager
$33,300,000
April 2012
IPO
Co-manager
$82,300,000
March 2012
PIPE
Exclusive placement agent
$7,200,000
March 2012
IPO
Co-manager
$88,000,000
March 2012
PIPE
Co-placement agent
$9,000,000
January 2012
Has acquired Environmental Systems Products
Exclusive financial advisor
$9,700,000
December 2011
Has acquired FAS Controls Inc.
Exclusive financial advisor
December 2011
IPO
Co-manager
$88,000,000
December 2011
Series B preferred stock
Exclusive placement agent and financial advisor
$2,050,000
September 2011
Series C preferred stock
Exclusive financial advisor
$21,000,000
September 2011
Has acquired Integrated Revenue Management
Exclusive financial advisor
March 2011
Has been sold to Falck Holdings A/S
Financial advisor
January 2011
Registered direct
Co-lead placement agent
$13,100,000
October 2010
Raised capital from Abraxis BioScience
Financial advisor
Investment banking and corporate finance services are offered through First Analysis Securities Corporation ("FASC" or "First Analysis Securities"), a subsidiary of First Analysis Corp.
©2021 by First Analysis Corporation.
One South Wacker Drive
  ·  
Suite 3900
  ·  
Chicago, IL 60606
  ·  
312-258-1400
First Analysis Securities Corp. (FASC) is a registered broker/dealer with FINRA and member SIPC.